purchase of all types of medicines (including pharmaceutical preparations) or vaccines. Tests: EGFR exon19 deletions or exon21(L858R) subsitution Hydralazine hydrochloride 20mg/ Ampoule I.V. Infusion or slow I.V Meropenem (as trihydrate or anhydrous) 500mg I.V.,I.V Infusion VialMesna 100mg/ml, (4ml) Injection vial or ampoule

Ministry of Health General Company for Marketing Medicines and Medical Supplies (Kimadia) Iraq has Released a tender for purchase of all types of medicines (including pharmaceutical preparations) or vaccines. Tests: EGFR exon19 deletions or exon21(L858R) subsitution Hydralazine hydrochloride 20mg/ Ampoule I.V. Infusion or slow I.V Meropenem (as trihydrate or anhydrous) 500mg I.V.,I.V Infusion VialMesna 100mg/ml, (4ml) Injection vial or ampoule in Pharmaceuticals. The tender was released on Mar 03, 2025.

Country - Iraq

Summary - purchase of all types of medicines (including pharmaceutical preparations) or vaccines. Tests: EGFR exon19 deletions or exon21(L858R) subsitution Hydralazine hydrochloride 20mg/ Ampoule I.V. Infusion or slow I.V Meropenem (as trihydrate or anhydrous) 500mg I.V.,I.V Infusion VialMesna 100mg/ml, (4ml) Injection vial or ampoule

Deadline - Mar 30, 2025

MT reference number - 104297717

Product classification - Pharmaceutical products